Consolidated Statement of Cash Flows - USD ($) $ in Thousands |
12 Months Ended | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2024 |
||||||||||||||||||||
| Operating activities | ||||||||||||||||||||||
| Profit/(loss) before income tax | $ 46,424 | $ (249,050) | [1] | $ (75,696) | [1] | |||||||||||||||||
| Adjustments for: | ||||||||||||||||||||||
| Depreciation and amortisation expense | 23,630 | 24,983 | [1] | 22,146 | [1] | |||||||||||||||||
| Employee share awards expense | 3,663 | 1,711 | [1] | (155) | [1] | |||||||||||||||||
| Fair value adjustments to financial instruments | [2] | 0 | (2,942) | [1] | 0 | [1] | ||||||||||||||||
| Gain on bargain purchase | [3] | (33,109) | 0 | [1] | 0 | [1] | ||||||||||||||||
| Impairment and write down of financial assets | 0 | 354 | [1] | 5,333 | [1] | |||||||||||||||||
| Impairment/(reversal of impairment) of non-financial assets | [4],[5] | (156,013) | 175,612 | [1] | 11,189 | [1] | ||||||||||||||||
| Income from sale of tax benefits under flow through share arrangements | [6] | 0 | (3,937) | [1] | (3,471) | [1] | ||||||||||||||||
| Net financial income and expenses | (725) | 670 | [1] | (1,918) | [1] | |||||||||||||||||
| Net loss on disposal of financial and non-financial assets | 102 | 0 | [1] | 828 | [1] | |||||||||||||||||
| Adjustments for losses (gains) on disposal of financial and non-financial assets | 102 | 0 | [1] | 828 | [1] | |||||||||||||||||
| Net movement in inventories relating to net realisable value adjustments | (9,454) | 2,718 | [1] | 6,843 | [1] | |||||||||||||||||
| Write down on settlement of pre-existing contractual arrangement | [3] | 137,000 | 0 | [1] | 0 | [1] | ||||||||||||||||
| Changes in assets and liabilities: | ||||||||||||||||||||||
| Trade and other receivables | (22,284) | (4,226) | [1] | (6,763) | [1] | |||||||||||||||||
| Inventories | (17,873) | 14,659 | [1] | (24,340) | [1] | |||||||||||||||||
| Other assets | 2,683 | 2,600 | [1] | 3,420 | [1] | |||||||||||||||||
| Trade and other payables | (1,791) | (3,482) | [1] | 12,439 | [1] | |||||||||||||||||
| Provisions and other liabilities | (17,829) | 28,384 | [1] | 3,387 | [1] | |||||||||||||||||
| Cash used in operations | (45,576) | (11,946) | [1] | (46,758) | [1] | |||||||||||||||||
| Interest received | 2,653 | 2,882 | [1] | 5,027 | [1] | |||||||||||||||||
| Interest paid | (682) | (539) | [1] | (647) | [1] | |||||||||||||||||
| Net cash flows used in operating activities | (43,605) | [7] | (9,603) | [1] | (42,378) | [1] | ||||||||||||||||
| Investing activities | ||||||||||||||||||||||
| Exploration expenditure | (503) | (20,398) | [1] | (17,230) | [1] | |||||||||||||||||
| Exploration expenditure expensed and included in operating cash flows | 503 | 1,011 | [1] | 0 | [1] | |||||||||||||||||
| Purchases of property, plant and equipment | (24,027) | (12,729) | [1] | (67,172) | [1] | |||||||||||||||||
| Advances to affiliates | (1,397) | 0 | [1] | 0 | [1] | |||||||||||||||||
| Cash outflows from investing activities | (25,424) | (32,116) | [1] | (84,402) | [1] | |||||||||||||||||
| Cash and cash equivalents acquired on business combination | 34,452 | 0 | [1] | 0 | [1] | |||||||||||||||||
| Proceeds from sale of financial assets | 0 | 0 | [1] | 9,630 | [1] | |||||||||||||||||
| Proceeds from sale of property, plant and equipment | 2,913 | 0 | [1] | 0 | [1] | |||||||||||||||||
| Net cash flows from/(used in) investing activities | 11,941 | (32,116) | [1] | (74,772) | [1] | |||||||||||||||||
| Financing activities | ||||||||||||||||||||||
| Proceeds from non-controlling interests | 0 | 6,761 | [1] | 17,728 | [1] | |||||||||||||||||
| Proceeds from interest bearing liabilities | 0 | 770 | [1] | 0 | [1] | |||||||||||||||||
| Repayment of interest bearing liabilities | (4,146) | (2,223) | [1] | (1,789) | [1] | |||||||||||||||||
| Proceeds from issue of shares and exercise of options | 253,891 | 25,899 | [1] | 25,413 | [1] | |||||||||||||||||
| Transaction costs associated with share issues | (9,144) | (1,330) | [1] | (794) | [1] | |||||||||||||||||
| Net cash flows from financing activities | 240,601 | 29,877 | [1] | 40,558 | [1] | |||||||||||||||||
| Net increase/(decrease) in cash and cash equivalents | 208,937 | (11,842) | [1] | (76,592) | [1] | |||||||||||||||||
| Cash and cash equivalents at the beginning of the financial year | [1] | 47,254 | [8] | 60,464 | 139,932 | |||||||||||||||||
| Foreign exchange rate differences on cash and cash equivalents | (912) | (1,368) | [1] | (2,876) | [1] | |||||||||||||||||
| Cash and cash equivalents at the end of the financial year | $ 255,279 | [8] | $ 47,254 | [1],[8] | $ 60,464 | [1] | ||||||||||||||||
| ||||||||||||||||||||||